Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
Study sponsor: LianBio LLC
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-09-15Actual
Enrollment · participants163Actual
Source updated2024-05-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.